arginine has been researched along with Broad Beta Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Innerarity, TL; Mahley, RW; Weisgraber, KH | 1 |
Gerich, JE; Havel, RJ; Kane, JP; Soeldner, JS; Tan, MH | 1 |
Dobmeyer, J; Feussner, G; Lohrmann, J | 1 |
Albanese, M; Feussner, G; Mann, WA; Schuster, H; Valencia, A | 1 |
Chen, M; Feussner, G; Fisher, E; Hoffmann, MM; März, W; Nauck, M; Scharnagl, H; Wieland, H | 1 |
Ballantyne, D; Ballantyne, FC; Stromberg, P | 1 |
Brewer, HB; Lohse, P; Rader, DJ | 1 |
Brewer, HB; Lohse, P; Mann, WA; Stein, EA | 1 |
Brennan, SO; George, PM; Janus, ED; Nye, ER; Rall, SC; Wardell, MR; Weisgraber, KH | 1 |
9 other study(ies) available for arginine and Broad Beta Disease
Article | Year |
---|---|
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
Topics: Apolipoproteins; Apolipoproteins E; Arginine; Cysteamine; Cysteine; Homozygote; Humans; Hyperlipoproteinemia Type III; Kinetics; Lipoproteins, LDL; Receptors, Cell Surface; Receptors, LDL | 1982 |
Pancreatic alpha and beta cell function in familial dysbetalipoproteinemia.
Topics: Adult; Aged; Arginine; Blood Glucose; Cholesterol; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperlipoproteinemia Type III; Insulin; Islets of Langerhans; Male; Middle Aged; Triglycerides | 1980 |
Rapid and reliable identification of human apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) variant.
Topics: Apolipoproteins E; Arginine; Aspartic Acid; Cysteine; Glycine; Humans; Hyperlipoproteinemia Type III; Isoelectric Focusing; Mutation; Polymerase Chain Reaction | 1995 |
Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Topics: Adolescent; Adult; Age of Onset; Aged; Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Base Sequence; Cysteine; Female; Genetic Variation; Heparin; Humans; Hyperlipoproteinemia Type III; Isoelectric Focusing; Lipoproteins; Male; Middle Aged; Molecular Sequence Data; Pedigree; Protein Structure, Secondary; Sequence Analysis, DNA | 1996 |
Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
Topics: Adult; Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Base Sequence; Cells, Cultured; Cysteine; Female; Fibroblasts; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lipoproteins, VLDL; Male; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Receptors, LDL | 1998 |
Metabolic defect in type-III hyperlipoproteinaemia.
Topics: Apolipoprotein C-II; Apolipoproteins C; Arginine; Humans; Hyperlipoproteinemia Type III; Lipoproteins, LDL; Lipoproteins, VLDL | 1977 |
Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.
Topics: Adolescent; Adult; Aged; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Arginine; Child; Cysteine; DNA; Electrophoresis, Polyacrylamide Gel; Female; Genes, Dominant; Glutamates; Glutamic Acid; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type III; Lysine; Male; Middle Aged; Pedigree; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 1992 |
Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
Topics: Adult; Amino Acid Sequence; Animals; Apolipoprotein E4; Apolipoproteins E; Arginine; Base Sequence; Cystine; DNA; Electrophoresis, Polyacrylamide Gel; Exons; Female; Glutamine; Humans; Hyperlipoproteinemia Type III; Lysine; Molecular Sequence Data; Mutation; Polymorphism, Restriction Fragment Length; Restriction Mapping | 1991 |
Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
Topics: Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Cysteine; Diseases in Twins; Electrophoresis, Gel, Two-Dimensional; Genetic Variation; Heterozygote; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type V; Lipoproteins; Male; Middle Aged; Peptide Mapping; Protein Conformation; Receptors, LDL | 1990 |